Novartis researchers leverage in-house startup initiative to begin digital technology research collaboration.

Learn about the career of our Global Medical Affairs Head for Solid Tumors and Rare Diseases.

The disease hobbles families and economies.

Investing in innovative treatments is vital to alleviate the suffering caused by multiple sclerosis (MS).

The Novartis Faculty of Scholars initiative connects academic researchers with deep knowledge and big ideas to scientists in its drug discovery labs.

Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.

From an eccentric idea to a revolution in medicine – the history of immunotherapy and a peek into its future.

Novartis is developing an experimental drug for weight loss.

All treatments that exist today started with patients volunteering to participate in a study and healthcare professionals offering their expertise.